134 related articles for article (PubMed ID: 9538001)
1. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
Bryk R; Wolff DJ
Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
[TBL] [Abstract][Full Text] [Related]
2. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
Bryk R; Lubeskie A; Wolff DJ
Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
[TBL] [Abstract][Full Text] [Related]
5. Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm.
Harkin DW; Rubin BB; Romaschin A; Lindsay TF
J Surg Res; 2004 Aug; 120(2):230-41. PubMed ID: 15234218
[TBL] [Abstract][Full Text] [Related]
6. Effect of L-N6-(1-iminoethyl)-lysine, an inducible nitric oxide synthase inhibitor, on murine immune response induced by Actinobacillus actinomycetemcomitans lipopolysaccharide.
Sosroseno W; Musa M; Ravichandran M; Fikri Ibrahim M; Bird PS; Seymour GJ
J Periodontal Res; 2007 Apr; 42(2):124-30. PubMed ID: 17305870
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury.
Louin G; Marchand-Verrecchia C; Palmier B; Plotkine M; Jafarian-Tehrani M
Neuropharmacology; 2006 Feb; 50(2):182-90. PubMed ID: 16242164
[TBL] [Abstract][Full Text] [Related]
8. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
[TBL] [Abstract][Full Text] [Related]
9. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
[TBL] [Abstract][Full Text] [Related]
10. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine.
Walker LM; Walker PD; Imam SZ; Ali SF; Mayeux PR
J Pharmacol Exp Ther; 2000 Oct; 295(1):417-22. PubMed ID: 10992009
[TBL] [Abstract][Full Text] [Related]
11. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma.
Vermeire K; Thielemans L; Matthys P; Billiau A
J Leukoc Biol; 2000 Jul; 68(1):119-24. PubMed ID: 10914498
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria is reduced by inhibition of inducible nitric oxide synthase in rat renal ischemia-reperfusion injury.
Kadkhodaee M; Zahmatkesh M; Sadeghipour HR; Eslamifar A; Taeb J; Shams A; Mahdavi-Mazdeh M
Transplant Proc; 2009 Sep; 41(7):2907-9. PubMed ID: 19765470
[TBL] [Abstract][Full Text] [Related]
13. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
Cooper GR; Barr A; Wolff DJ
Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis.
Gabbai FB; Boggiano C; Peter T; Khang S; Archer C; Gold DP; Kelly CJ
J Immunol; 1997 Dec; 159(12):6266-75. PubMed ID: 9550431
[TBL] [Abstract][Full Text] [Related]
15. Post-translational modification of manganese superoxide dismutase in acutely rejecting cardiac transplants: role of inducible nitric oxide synthase.
Nilakantan V; Halligan NL; Nguyen TK; Hilton G; Khanna AK; Roza AM; Johnson CP; Adams MB; Griffith OW; Pieper GM
J Heart Lung Transplant; 2005 Oct; 24(10):1591-9. PubMed ID: 16210135
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
17. Effect of inhibition of inducible nitric oxide synthase (iNOS) on the murine splenic immune response induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans lipopolysaccharide.
Sosroseno W; Musa M; Ravichandran M; Ibrahim MF; Bird PS; Seymour GJ
Eur J Oral Sci; 2008 Feb; 116(1):31-6. PubMed ID: 18186729
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ
Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424
[TBL] [Abstract][Full Text] [Related]
19. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
Nagareddy PR; McNeill JH; MacLeod KM
Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
[TBL] [Abstract][Full Text] [Related]
20. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]